Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Home Intensive Care Pharmacy, Inc.
483
•Home Intensive Care Pharmacy, Inc.•March 1, 2013

Home Intensive Care Pharmacy, Inc. – FDA 483, Mar 1, 2013

Record Details

The FDA Form 483 details multiple deficiencies at a facility producing sterile drug products, including intrathecal medications like Morphine/Bupivacaine.

**Violations and Observations:**

* **Aseptic Procedures:** The firm lacks written procedures for aseptic operations in ISO 5 and ISO 7 areas. A pharmacist was observed resting elbows on an ISO 5 laminar air-flow hood workbench and had exposed forearm skin due to a gap between non-sterile lab coat sleeves and sterile gloves during aseptic filling. * **Gowning Requirements:** Gowning procedures are inadequate and not formally documented for ISO 8, ISO 7, and ISO 5 areas. Observed gowning (single sterile gloves, non-sterile shoe covers, non-sterile lint-free lab coat, hair net, ear-loop face mask) left exposed skin around eyes, forehead, and neck during sterile drug processing. * **Facility and Equipment Design:** No evaluation of equipment contact surfaces or facility layout to prevent contamination in classified areas. ISO 5 laminar air-flow hood workbenches are made of particle board with a laminated surface. Smoke studies and pressure differential limits for ISO 5, ISO 7, and ISO 8 areas were only performed under static conditions, not dynamically. Pressure differentials between ISO 7 and ISO 8 are not actively monitored, and no limits are set; no apparent difference in pressure readings was observed, along with a spatial gap in the doorway between

Company
Home Intensive Care Pharmacy, Inc.
Inspection date
March 1, 2013
Product type
Drugs
Office
Dallas District Office
People
  • Christopher D. Leach (Compliance Officer at FDA)
  • Lucas B. Leake (Investigator)
View Company Profile

ID · 90599849-9cdb-4b0a-a2fb-25e7e07df46f

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Home Intensive Care Pharmacy, Inc.
  • 483 - 2015-05-05May 5, 2015
  • STATE_REFERRAL_LETTER - 2015-04-20April 20, 2015
  • WARNING_LETTER - 2013-03-01March 1, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Home Intensive Care Pharmacy, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.